Microbiome Technologies Energizing Pharma and Life Sciences

LONDON, July 24, 2017 /PRNewswire/ -- A New World of Microbiome Innovations 
 
Microbiome science has become a key area of research for biopharmaceutical companies. At present, there are multiple start-ups emerging, which are focusing their resources towards the development of novel therapeutics as well as diagnostic/screening technologies and services. 

Download the full report: https://www.reportbuyer.com/product/5001044/

In an era of personalized medicine, the current trajectory of growth witness across the microbiome industry parallels, the growth that took place across genomics. Some of the milestones that have occurred in the microbiome field are the application of next generation screening towards identifying and assessing microbial levels within the human gut. 

Using these microbial biomarkers, scientists are pushing the boundaries by identifying novel drug targets as well as probiotic or prebiotic products that could aid in balancing the microbial ecosystem within the human body. 

Download the full report: https://www.reportbuyer.com/product/5001044/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/microbiome-technologies-energizing-pharma-and-life-sciences-300493105.html

SOURCE ReportBuyer